Literature DB >> 21248156

Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients.

M Mikulska1, E Furfaro, V Del Bono, F Gualandi, M T Van Lint, F Miletich, A Bacigalupo, C Viscoli.   

Abstract

In 6 hematopoietic stem cell transplant (HSCT) recipients with candidemia, the (1,3)-β-d-glucan (BG) test was positive a median of 2.5 days after a positive blood culture. Only in 1 patient did BG positivity precede positive blood cultures. BG concentrations decreased in patients with clinical response, but positive BG results persisted long after blood cultures became sterile (median, 48 days).

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21248156      PMCID： PMC3067381          DOI： 10.1128/CVI.00513-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  6 in total

1.  Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Authors:  Luis Ostrosky-Zeichner; Barbara D Alexander; Daniel H Kett; Jose Vazquez; Peter G Pappas; Fumihiro Saeki; Paul A Ketchum; John Wingard; Robert Schiff; Hiroshi Tamura; Malcolm A Finkelman; John H Rex
Journal:  Clin Infect Dis       Date:  2005-07-21       Impact factor: 9.079

2.  Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Jerry W Pickering; Howard W Sant; Catherine A P Bowles; William L Roberts; Gail L Woods
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.

Authors:  Michael Ellis; Basel Al-Ramadi; Malcolm Finkelman; Ulla Hedstrom; Jorgen Kristensen; Hussein Ali-Zadeh; Lena Klingspor
Journal:  J Med Microbiol       Date:  2008-03       Impact factor: 2.472

4.  Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Florence Persat; Stéphane Ranque; Francis Derouin; Annie Michel-Nguyen; Stéphane Picot; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

5.  Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.

Authors:  Sophia Koo; Julie M Bryar; John H Page; Lindsey R Baden; Francisco M Marty
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

6.  1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

Authors:  Laurence Senn; James Owen Robinson; Sabine Schmidt; Marlies Knaup; Nobuo Asahi; Shinji Satomura; Shuuji Matsuura; Bertrand Duvoisin; Jacques Bille; Thierry Calandra; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079
  6 in total
  9 in total

1.  Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.

Authors:  S Koo; L R Baden; F M Marty
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

2.  Persistence of high-level (1,3)-β-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient.

Authors:  A Naselli; M Faraci; E Lanino; G Morreale; G Cangemi; R Bandettini; E Castagnola
Journal:  Bone Marrow Transplant       Date:  2014-09-22       Impact factor: 5.483

3.  β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.

Authors:  Estrella Martín-Mazuelos; Ana Loza; Carmen Castro; Desirée Macías; Ismail Zakariya; Pedro Saavedra; Sergio Ruiz-Santana; Elena Marín; Cristóbal León
Journal:  Intensive Care Med       Date:  2015-07-02       Impact factor: 17.440

4.  Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.

Authors:  Valerio Del Bono; Emanuele Delfino; Elisa Furfaro; Malgorzata Mikulska; Elena Nicco; Paolo Bruzzi; Alessandra Mularoni; Matteo Bassetti; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

5.  Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.

Authors:  Dionysios Neofytos; Radha Railkar; Kathleen M Mullane; David N Fredricks; Bruno Granwehr; Kieren A Marr; Nikolaos G Almyroudis; Dimitrios P Kontoyiannis; Johan Maertens; Rebecca Fox; Cameron Douglas; Robert Iannone; Eunkyung Kauh; Norah Shire
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

6.  Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.

Authors:  Cécile Angebault; Fanny Lanternier; Frédéric Dalle; Cécile Schrimpf; Anne-Laure Roupie; Aurélie Dupuis; Aurélie Agathine; Anne Scemla; Etienne Paubelle; Denis Caillot; Bénédicte Neven; Pierre Frange; Felipe Suarez; Christophe d'Enfert; Olivier Lortholary; Marie-Elisabeth Bougnoux
Journal:  Open Forum Infect Dis       Date:  2016-06-16       Impact factor: 3.835

Review 7.  Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease.

Authors:  Malcolm A Finkelman
Journal:  J Fungi (Basel)       Date:  2020-12-29

8.  Role of (1-3)-Β-D-Glucan Test in the Diagnosis of Invasive Fungal Infections among High-Risk Patients in a Tertiary Care Hospital.

Authors:  Tanureet Kaur Sandhar; Deepinder Kaur Chhina; Veenu Gupta; Jyoti Chaudhary
Journal:  J Lab Physicians       Date:  2022-02-09

Review 9.  Beta-D-Glucan in Patients with Haematological Malignancies.

Authors:  Malgorzata Mikulska; Elisa Balletto; Elio Castagnola; Alessandra Mularoni
Journal:  J Fungi (Basel)       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.